Clinical trial
An Open-label, Randomized, Multi-center, Parallel-group Clinical Trial Comparing the Efficacy and Safety of GP40081 (OOO "GEROPHARM", Russia) Compared to NovoMix® 30 FlexPen® (Novo Nordisk A/S, Denmark) in Type 2 Diabetes Mellitus Patients
NCT04226105 is registered in ClinicalTrials.gov with Geropharm as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Randomized, Multi-center, Parallel-group Clinical Trial Comparing the Efficacy and Safety of GP40081 (OOO "GEROPHARM", Russia) Compared to NovoMix® 30 FlexPen® (Novo Nordisk A/S, Denmark) in Type 2 Diabetes Mellitus Patients
- Lead sponsor
- Geropharm
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- January 20, 2020
- Completion date
- December 25, 2020
- Enrollment
- 264 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.